Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2022
|
Jules A. Maltz Director |
BUY
Other acquisition or disposition
|
Direct |
9,207
+24.61%
|
-
|
|
Mar 17
2022
|
Lynne Chou O'Keefe Director |
SELL
Open market or private sale
|
Direct |
10,044
-100.0%
|
$40,176
$4.5 P/Share
|
|
Mar 15
2022
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,958
-8.24%
|
$87,832
$4.34 P/Share
|
|
Mar 15
2022
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,211
+13.4%
|
-
|
|
Mar 15
2022
|
Kristen Green Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,794
+50.0%
|
-
|
|
Mar 15
2022
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,044
+50.0%
|
-
|
|
Mar 15
2022
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,121
+26.32%
|
-
|
|
Mar 15
2022
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,121
+50.0%
|
-
|
|
Mar 15
2022
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,248
-21.06%
|
$20,992
$4.34 P/Share
|
|
Mar 15
2022
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,913
+35.83%
|
-
|
|
Mar 15
2022
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
564
+9.99%
|
-
|
|
Mar 15
2022
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,044
+2.39%
|
-
|
|
Mar 15
2022
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,920
-1.47%
|
$23,680
$4.34 P/Share
|
|
Mar 15
2022
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,344
+5.71%
|
-
|
|
Mar 15
2022
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,794
+50.0%
|
-
|
|
Mar 15
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,487
-1.03%
|
$13,948
$4.34 P/Share
|
|
Mar 15
2022
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,089
+2.89%
|
-
|
|
Mar 15
2022
|
Jules A. Maltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,794
+34.01%
|
-
|
|
Mar 14
2022
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
120,059
+24.12%
|
$0
$0.4 P/Share
|
|
Mar 02
2022
|
Lynne Chou O'Keefe Director |
SELL
Open market or private sale
|
Direct |
40,178
-100.0%
|
$200,890
$5.04 P/Share
|
|
Mar 01
2022
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
14,585
-57.0%
|
$72,925
$5.25 P/Share
|
|
Mar 01
2022
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,178
+50.0%
|
-
|
|
Feb 28
2022
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
86,820
-41.24%
|
$434,100
$5.17 P/Share
|
|
Feb 28
2022
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
189,682
+27.54%
|
$379,364
$2.26 P/Share
|
|
Feb 07
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,516
-6.94%
|
$98,064
$4.41 P/Share
|
|
Feb 04
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,516
-6.49%
|
$98,064
$4.41 P/Share
|
|
Feb 03
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,516
-6.1%
|
$98,064
$4.59 P/Share
|
|
Jan 20
2022
|
Andrew Dudum Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
1,500
+50.0%
|
$7,500
$5.17 P/Share
|
|
Dec 29
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
5,000,000
+50.0%
|
-
|
|
Dec 29
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
5,000,000
-74.16%
|
-
|
|
Dec 29
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,345
+2.98%
|
$24,690
$2.43 P/Share
|
|
Dec 15
2021
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,368
-6.16%
|
$8,208
$6.35 P/Share
|
|
Dec 15
2021
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,648
+20.26%
|
-
|
|
Dec 15
2021
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
565
+11.11%
|
-
|
|
Dec 15
2021
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,178
+9.12%
|
-
|
|
Dec 15
2021
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,572
-3.58%
|
$57,432
$6.35 P/Share
|
|
Dec 15
2021
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,342
+8.35%
|
-
|
|
Dec 15
2021
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,255
-1.33%
|
$31,530
$6.35 P/Share
|
|
Dec 15
2021
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,092
+2.49%
|
-
|
|
Dec 15
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,053
-8.92%
|
$132,318
$6.35 P/Share
|
|
Dec 15
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,210
+14.29%
|
-
|
|
Dec 15
2021
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,509
-14.98%
|
$27,054
$6.35 P/Share
|
|
Dec 15
2021
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,913
+31.61%
|
-
|
|
Dec 14
2021
|
Jack Abraham > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-12.24%
|
$5,000,000
$5.55 P/Share
|
|
Dec 13
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
81,100
+50.0%
|
$405,500
$5.93 P/Share
|
|
Dec 01
2021
|
Ambar Bhattacharyya Director |
BUY
Other acquisition or disposition
|
Direct |
1,842
+10.09%
|
-
|
|
Dec 01
2021
|
Jules A. Maltz Director |
BUY
Other acquisition or disposition
|
Direct |
9,207
+50.0%
|
-
|
|
Sep 22
2021
|
Andrew Dudum Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
2,874,769
+50.0%
|
-
|
|
Sep 22
2021
|
Andrew Dudum Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
2,874,769
-34.92%
|
-
|
|
Sep 15
2021
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,572
-3.79%
|
$76,576
$8.66 P/Share
|